Health
Commercial assays detect mRNA-1273 and BNT162b2 vaccine-induced SARS-CoV-2 antibodies in most vaccinated participants – News-Medical.Net
A recent study by researchers from Canada aimed to examine the ability of commercial assays to detect vaccine-induced antibodies and recognize the vaccination response….
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Immunoglobulin G (IgG) high throughput serology assays have so far been used mainly to conduct seroprevalence studies in large cohorts to help public health decision making.
All recent seroprevalence studies only examined the detection of antibodies from natural SARS-CoV-2 infection. While most of the vaccine candidates produced detectable antibody levels in serological research assays in early phase trials, it is not clear how existing…
-
Noosa News14 hours agoRevealed: 75 Qld suburbs you could afford to buy in if lending standards drop
-
General9 hours agoFarmers develop ‘autofill’ tech so agricultural robots can operate around the clock
-
Business13 hours agoWhere to invest $20,000 into ASX 200 shares after the market selloff
-
General10 hours agoChoosing an online exercise program can be confusing. Here’s what to look out for